Proteus Digital Health

Mighty Things

For the Connected World

Swallow Your Sensor

“Twenty years from now, every medicine will have a chip in it. Once it’s clear that a digital medicine is a more powerful product than a dumb medicine, and that the cost is reasonable, why would anyone use the dumb medicine?” – Andrew Thompson, CEO and co-founder of Proteus Digital Health.

Redwood City, Calif.-based Proteus Digital Health is working to create a new category of products and services called Digital Medicines. Those will be the same pharmaceuticals you take today, with one small change: each pill will also contain a tiny sensor that can communicate, via a digital health feedback system, vital information about your medication-taking behaviors and how your body is responding.

The system uses a tiny ingestible sensor that patients swallow with their medication every day. The sensor contains tiny amounts of magnesium and copper that react together and send a signal to a battery-operated patch that’s worn on the patient’s abdomen. The patch, which lasts about a week, reports its data to a tablet or smartphone via Bluetooth, and the device forwards the information up to the cloud. Once the data is in the cloud, doctors and other caregivers can monitor it.

A handful of health systems in the U.S. and U.K. are now testing the Proteus system in a “private beta.” The investing communities are also big believers: Proteus’ most recent round of funding this July, its seventh, generated an additional $172 million, driving the total to around $400 million. Proteus lists Carlyle, Essex Woodlands, Kaiser Permanente, Medtronic, Novartis, Otsuka, Oracle, and ON Semiconductor as existing investors.

Your thoughts, please

Your email address will not be published. Required fields are marked *